glp-1 physiology informs the pharmacotherapy of obesity GLP-1-based therapies for diabetes, and beyond Adipose Tissue Plasticity, Lipoprotein Metabolism,
Description
GLP-1 medications have been shown to have many benefits in treating obesity and type 2 diabetes
however, larger doses were associated with greater side effects, primarily nausea
1 the agency has made more than 198 seizures of medication labeled as Ozempic
doi:10.1001/jamaoto.2024.4852 Written by Dr
